Fund objective
To provide a total return to shareholders in excess of that of the FTSE All-Share Index and pay a progressive dividend.
Fund Information
| Fund launch date |
3 January 1959 |
| Fund manager |
Peter Cockburn |
| Fund size |
£29.8m |
| Base currency |
GBP |
| Benchmark |
FTSE All-Share Index |
| IMA sector |
UK All Companies |
| Income yield |
n/a |
| Valuation Point |
n/a |
| SWIP code |
UKSEL |
| ISIN code |
n/a |
| SEDOL code |
0461823 |
| Bloomberg code |
n/a |
| BP |
8.6% |
| GlaxoSmithkline |
8.5% |
| Indus Gas |
6.7% |
| Reed Elsevier |
6.5% |
| Resolution |
5.3% |
| AstraZeneca |
4.7% |
| Berkeley Group |
4.3% |
| Smiths Group |
4.2% |
| KSK Power Venture |
3.9% |
| Glencore International |
3.1% |
Source: SWIP
All data as at 31 December 2011 unless otherwise stated
You should note that the value of your investment can go down as well as up and investors may not get back the full amount invested.
The Fund may have holdings which are denominated in different currencies and may be affected by movements in exchange rates. Consequently, the value of the investment may rise or fall in line with the exchange rates.
Further details of the specific risks relating to investment in a Fund can be found in the relevant Prospectus and the Simplified Prospectus or Key Investor Information Document (KIID).